JCRB0178.0 KP-3
Cell information
Cell type:general cells (View Pricing Information)
| JCRB No. | JCRB0178.0 | Cell Name | KP-3 |
|---|---|---|---|
| Profile | A metastasis of adenosquamous carcinoma of the human pancreatic duct. | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | M | Age | 75 |
| Identity | available | Tissue for Primary Cancer | pancreas |
| Case history | pancreatic tumor | Metastasis | Yes |
| Tissue Metastasized | liver | Genetics | |
| Life Span | infinite | Crisis PDL | |
| Morphology | epithelial-like | Character | A metastasis of adenosquamous carcinoma of the pancreatic duct. |
| Classify | tumor | Established by | Kono,A. et. al. |
| Registered by | Iguchi,H. | Regulation for Distribution | |
| Comment | Unique bat the pattern was similar to the KP-3L which is reported to be derived from the KP-3. | Year | 2001 |
| Medium | RPMI1640 medium with 10% fetal bovine serum. | Methods for Passages | Cells are harvested after treatment with 0.02% EDTA and 0.1% trypsin. Subculture when cells reach to subconfluent. |
| Cell Number on Passage | 1-2 x 10^5 cells/T25 frask | Race | Japanese |
| CO2 Conc. | 5 % | Tissue Sampling | pancreas |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:9735394 | Alteration of the CDKN2A gene in pancreatic cancers: Is it a late event in the progression of pancreatic cancer? Sugimoto Y,Morita R,Hikiji K,Imura G,Ogata Y,Yasuda D,Kono A,Iguchi H Int J Oncol. 1998 Oct;13(4):669-76 |
| Pubmed id:21607521 | Alterations of the p53 tumor-suppressor gene and ki-ras oncogene in human pancreatic cancer-derived cell-lines with different metastatic potential. Iguchi H,Morita R,Yasuda D,Takayanagi R,Ikeda Y,Takada Y,Shimazoe T,Nawata H,Kono A Oncol Rep. 1994 Nov;1(6):1223-7 |
| Pubmed id:2172194 | Establishment and characterization of human pancreatic cancer cell lines in tissue culture and in nude mice. Ikeda Y,Ezaki M,Hayashi I,Yasuda D,Nakayama K,Kono A Jpn J Cancer Res. 1990 Oct;81(10):987-93 |
| Images |
|---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
| Movies |
|---|
|
|
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | JCRB0178.0 | Cell Name | KP-3 |
|---|---|---|---|
| LOT No. | 12012006 | Lot Specification | distribution |
| Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS lot; GIBCO 4518333S) | Temperature | 37 C |
| Cell Density at Seeding | 4 x 10^4 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA. |
| Doubling Time | approx. 28 hrs | Cell Number in Vial (cells/1ml) | 2.1 x 10^6 |
| Viability at cell freezing (%) | 97.1 | Antibiotics Used | free |
| Passage Number | Unknown (8 at bank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), LD, MD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0178.0 | Cell Name | KP-3 |
|---|---|---|---|
| LOT No. | 09272001 | Lot Specification | distribution |
| Medium | RPMI1640 medium with 10% fetal calf serum(Intergen RB52405). | Temperature | 37 C |
| Cell Density at Seeding | 2.5 x 10^4 | Methods for Passages | Cells harvested after treatment with 0.1% trypsin. |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.4 x 10^6 |
| Viability at cell freezing (%) | 95.6 | Antibiotics Used | free |
| Passage Number | P5* | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | G6PD(typeB), NP, LDH examine. Human not a HeLa. |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | D5S818:13 D13S317:9,11 D7S820:10,12 D16S539:9,13 VWA:17,18 TH01:6,10 AM:X TPOX:9,11 CSF1PO:12 |
| Adhesion | Yes | Exoteric Gene | NT |
| Medium for Freezing | Culture medium containing 5% DMSO. | CO2 Conc. | 5 % |
| Viability immediately after thawing (%) | Additional information |
| Images |
|---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
| Cell No. | JCRB0178.0 | Cell Name | KP-3 |
|---|---|---|---|
| LOT No. | 07252014 | Lot Specification | distribution |
| Medium | RPMI1640 medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10091) | Temperature | 37 C |
| Cell Density at Seeding | 4.0 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
| Doubling Time | Cell Number in Vial (cells/1ml) | 3.2 x 10^6 | |
| Viability at cell freezing (%) | 81.0 | Antibiotics Used | free |
| Passage Number | Unknown (8 at bank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | D5S818:13 D13S317:9,11 D7S820:10,12 D16S539:9,13 VWA:18 TH01:6,9.3 AM:X TPOX:9,11 CSF1PO:12 |
|
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 81.0 | Additional information |
| Cell No. | JCRB0178.0 | Cell Name | KP-3 |
|---|---|---|---|
| LOT No. | 10112019 | Lot Specification | distribution |
| Medium | RPMI-1640 medium with 10% fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
| Cell Density at Seeding | 4 - 8 x 10^4 cells/ml | Methods for Passages | Cells were harvested after treatment with 0.1% trypsin. |
| Doubling Time | approx. 38 hrs | Cell Number in Vial (cells/1ml) | 1.8 x 10^6 |
| Viability at cell freezing (%) | 99.3 | Antibiotics Used | free |
| Passage Number | Unknown (8 at bank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 90 | Additional information |
| Cell No. | JCRB0178.0 | Cell Name | KP-3 |
|---|---|---|---|
| LOT No. | 01222024 | Lot Specification | distribution |
| Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; NICHIREI Cat. # 174112, Lot 20M00K) | Temperature | 37 C |
| Cell Density at Seeding | 0.7 - 2.1 x 10^5 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.1% trypsin and 0.02% EDTA. |
| Doubling Time | approx. 29 hrs. | Cell Number in Vial (cells/1ml) | 1.8 x 10^6 |
| Viability at cell freezing (%) | 98.6 | Antibiotics Used | free |
| Passage Number | Unknown (8 at bank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | D5S818:13 D13S317:9,11 D7S820:10,12 D16S539:9,13 VWA:18 TH01:6,9.3 AM:X TPOX:9,11 CSF1PO:12 |
|
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 5% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 90.0 | Additional information |













